Cynata Therapeutics Limited

ASX:CYP ISIN:AU000000CYP7

 
 

News

Regeneus Ltd (ASX:RGS) Appoints International Directors for Global Growth

🕔4/29/2019 8:48:54 AM 5441

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce the appointment of John Chiplin, PhD and Alan W. Dunton, M.D. to its Board of Directors, effective 29 April 2019 as independent, Non-Executive Directors.

Read Full Article

Chapmans Limited (ASX:CHP) to Make Strategic Medicinal Cannabis Sector Investment

🕔8/29/2017 12:35:47 PM 9425

The Directors of Chapmans Limited (ASX:CHP) are pleased to announce that the Company has entered into a Binding Heads of Agreement with MJ Life Sciences Pty Ltd, to make a strategic investment of US$500,000 in MJLS.

Read Full Article
###

4,765 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 9) (Last 30 Days: 36) (Since Published: 4765) 

Company Data

More News Results

  • 2025/04/24: March 2025 Quarterly Activity Report and Appendix 4C*
  • 2025/04/24: Australian Federal Government Announces Funding of SMART CRC*
  • 2025/04/14: Cynata Establishes New Scientific Advisory Board*
  • 2025/04/07: Promising Preclinical Heart Disease Data*
  • 2025/04/01: Appendix 3Ys x 4*
  • 2025/03/18: Cynata Presenting at Advanced Therapies Congress*
  • 2025/03/12: Cynata Participating in Euroz Hartleys Investor Conference*
  • 2025/02/27: Appendix 4D & Half-Year Financial Statements*
  • 2025/02/20: Appendix 3Y - Paul Wotton*
  • 2025/02/20: Application for quotation of securities - CYP*
*refer to company website